Your browser doesn't support javascript.
loading
Inverse remodelling of K2P3.1 K+ channel expression and action potential duration in left ventricular dysfunction and atrial fibrillation: implications for patient-specific antiarrhythmic drug therapy.
Schmidt, Constanze; Wiedmann, Felix; Zhou, Xiao-Bo; Heijman, Jordi; Voigt, Niels; Ratte, Antonius; Lang, Siegfried; Kallenberger, Stefan M; Campana, Chiara; Weymann, Alexander; De Simone, Raffaele; Szabo, Gabor; Ruhparwar, Arjang; Kallenbach, Klaus; Karck, Matthias; Ehrlich, Joachim R; Baczkó, István; Borggrefe, Martin; Ravens, Ursula; Dobrev, Dobromir; Katus, Hugo A; Thomas, Dierk.
  • Schmidt C; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Wiedmann F; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Zhou XB; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Heijman J; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Voigt N; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Ratte A; First Department of Medicine, University Medical Center Mannheim, Mannheim, Germany.
  • Lang S; Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
  • Kallenberger SM; Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Campana C; Institute of Pharmacology, West German Heart and Vascular Center, University Duisburg-Essen, Essen, Germany.
  • Weymann A; Institute of Pharmacology and Toxicology, University Medical Center Göttingen, Georg-August University Göttingen, Göttingen, Germany.
  • De Simone R; DZHK (German Center for Cardiovascular Research), Göttingen, Germany, partner site.
  • Szabo G; Department of Cardiology, University of Heidelberg, Heidelberg, Germany.
  • Ruhparwar A; DZHK (German Center for Cardiovascular Research), partner site Heidelberg/Mannheim, University of Heidelberg, Heidelberg, Germany.
  • Kallenbach K; First Department of Medicine, University Medical Center Mannheim, Mannheim, Germany.
  • Karck M; Department for Bioinformatics and Functional Genomics, Division of Theoretical Bioinformatics, German Cancer Research Center (DKFZ), Institute for Pharmacy and Molecular Biotechnology (IPMB) and BioQuant, Heidelberg University, Heidelberg, Germany.
  • Ehrlich JR; Cardiovascular Research Institute Maastricht, Maastricht University Medical Center, Maastricht, The Netherlands.
  • Baczkó I; Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Borggrefe M; Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Ravens U; Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Dobrev D; Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Katus HA; Department of Cardiac Surgery, University Hospital Heidelberg, Heidelberg, Germany.
  • Thomas D; INCCI Haerzzenter, Institut National de Chirurgie Cardiaque et de Cardiologie Interventionnelle, Luxembourg, Luxembourg.
Eur Heart J ; 38(22): 1764-1774, 2017 Jun 07.
Article en En | MEDLINE | ID: mdl-28057773
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Potenciales de Acción / Disfunción Ventricular Izquierda / Canales de Potasio de Dominio Poro en Tándem / Antiarrítmicos / Proteínas del Tejido Nervioso Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fibrilación Atrial / Potenciales de Acción / Disfunción Ventricular Izquierda / Canales de Potasio de Dominio Poro en Tándem / Antiarrítmicos / Proteínas del Tejido Nervioso Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male Idioma: En Año: 2017 Tipo del documento: Article